Trump administration cuts over $1 billion from NIH, ends sickle cell research project

---

Full Story

The Trump administration has cut more than $1 billion in grants from the National Institutes of Health this year. The reductions reportedly include funding for a study on sickle cell disease, which affects about 100,000 Americans.

Sickle cell disease is a genetic blood disorder that disrupts oxygen transport throughout the body. The Centers for Disease Control and Prevention reports that roughly 90% of those affected in the U.S. are Black.

MEDIA REPORTING

See how news sources on all sides are covering this story.

Left 32% | Right 26% | Center 32% | Unrated 11%

The Context

NIH, the nation’s primary medical research agency, funds studies across a range of diseases, including rare and underserved conditions. The funding cuts reported this year mark a significant shift in support for such research.

According to reports, the Trump administration’s reductions have already surpassed $1 billion. One project impacted is a study related to sickle cell disease.

Sickle cell research has long been underfunded despite its disproportionate impact on African American communities. Advocacy groups have routinely pushed for greater attention to this disease.

The decision to cut NIH funding has drawn criticism from those concerned about the impact on vulnerable populations. Others argue that federal spending should be reevaluated and prioritized elsewhere.

Historically, NIH budgets have enjoyed bipartisan support due to their impact on public health. However, debates over government spending frequently reignite calls for reductions in discretionary funding.

Supporters of the cuts contend that streamlining research efforts can increase efficiency. Opponents argue it risks exacerbating health disparities in already underserved communities.